Alnylam Pharmaceuticals, Inc. (ALNY)

  • Nasdaq: ALNY
  • Mkt.Cap.:596.93M
Focused: Healthcare > Biopharmaceuticals (^BPHRM)

Classification

Sector
Healthcare
Biopharmaceuticals
- Focused
- Sector Pure-Play

Sector companies

Top 5 competitive companies in Biopharmaceuticals (^BPHRM) :

Ticker Name Mkt.Cap.
PFE Pfizer Inc. 134.80B
NVS Novartis AG (ADR) 122.95B
RHHBY Roche Holding Ltd. (ADR) 122.07B
MRK Merck & Co., Inc. 110.90B
GSK GlaxoSmithKline plc (ADR) 102.56B

Relationships

Sample 8 relationships grouped by relationhip type.

Ticker Name
Competitors
Defined by the Company AVII AVI BioPharma, Inc.
Defined by the Company OPK Opko Health Inc.
Customers
Defined by the Company CBST Cubist Pharmaceuticals, Inc.
Defined by the Company BIIB Biogen Idec Inc.
Suppliers
Defined by the Company IDRA Idera Pharmaceuticals, Inc.
Defined by the Company ISIS ISIS Pharmaceuticals, Inc.
Partners
Defined by the Company CBST Cubist Pharmaceuticals, Inc.
Defined by the Company GSK GlaxoSmithKline plc (ADR)
- Defined by the Company
- Defined by Others

Products & Services

Sample products & services from Biopharmaceuticals (^BPHRM) :

  • ALN-HTT
  • ALN-PCS01 (Systemic RNAi Therapeutic)
  • ALN-RSV01 (RNAi Therapeutic)

Relative Performance (1Y)

Relative Chart
  • - Alnylam Pharmaceuticals, Inc. (ALNY)
  • - S&P 500 INDEX (SPX)
  • - Healthcare > Biopharmaceuticals (^BPHRM)

Subscribe to an RSS Feed Research Reports

more »